BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 15, 2026
See today's BioWorld
Home
» Takeda Tempted by Fate; Adds to Regenerative Medicine Effort
To read the full story,
subscribe
or
sign in
.
Takeda Tempted by Fate; Adds to Regenerative Medicine Effort
May 11, 2011
By
Jennifer Boggs
Fate Therapeutics Inc.'s approach to stem cell therapy – developing small-molecule drugs aimed at modulating adult stem cells – has attracted another investor: Takeda Ventures Inc.
BioWorld
